Illumina Inc

ILMN 
(NASDAQ) 
 
$ 290.50 <%= Resources.Global.txtUp %>
Updated 20/08/2019
Change % 2.06% Stock price increasing
Change 5.85 Stock price increasing
Volume 335,246
High $ 290.63
Low $ 284.71
Open $ 285.54
ISIN
Prev close $ 284.65
# of shares 147.00M
Market cap 42,704M USD
Intraday

Market closed
Illumina Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  290.50 2.0% Stock price increasing -2.6% Stock price decreasing -7.1% Stock price decreasing -3.5% Stock price decreasing -13.5% Stock price decreasing
Powered by TradingView

Company profile

Illumina is a major player in life science tools for analyzing genetic material. Revenue from microarray and genome sequencing machines and disposables make up most of the company's revenue, but approximately 18% of the company's sales come from testing services. Essentially all of Illumina's growth stems from the company's genome sequencing products, which include the company's high-throughput NovaSeq and HiSeq instruments in addition to its benchtop NextSeq, MiSeq, and MiniSeq, and iSeq product lines.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 August 2019 00:06:39
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB2 - 2019-08-22 01:06:39 - 2019-08-22 00:06:39 - 1000 - Website: OKAY